108 related articles for article (PubMed ID: 9116082)
1. Confounding by indication?
Shapiro S
Epidemiology; 1997 Jan; 8(1):110-1. PubMed ID: 9116082
[No Abstract] [Full Text] [Related]
2. Confounding by indication.
Walker AM
Epidemiology; 1996 Jul; 7(4):335-6. PubMed ID: 8793355
[No Abstract] [Full Text] [Related]
3. Confounding by indication, histamine-2 receptor antagonists, and gastric cancer.
Edwardes MD; Baltzan M
Epidemiology; 1997 May; 8(3):335. PubMed ID: 9115035
[No Abstract] [Full Text] [Related]
4. Histamine-2 receptor antagonists and gastric cancer.
Johnson AG; Jick SS; Perera DR; Jick H
Epidemiology; 1996 Jul; 7(4):434-6. PubMed ID: 8793372
[TBL] [Abstract][Full Text] [Related]
5. Confounding by indication and past clinical trials.
Porta M
Epidemiology; 1997 Mar; 8(2):219-20. PubMed ID: 9229221
[No Abstract] [Full Text] [Related]
6. Antisecretory drugs and gastric cancer.
Langman MJ
Br Med J (Clin Res Ed); 1985 Jun; 290(6485):1850-2. PubMed ID: 2860944
[No Abstract] [Full Text] [Related]
7. [Side-effects of H2-receptor antagonists].
Thuesen B; Knigge U; Christiansen PM
Ugeskr Laeger; 1986 May; 148(20):1191-5. PubMed ID: 2873670
[No Abstract] [Full Text] [Related]
8. [Adverse effects of H2 blockaders].
Arabehety AR
Acta Gastroenterol Latinoam; 1980; 10(4):317-23. PubMed ID: 6115533
[No Abstract] [Full Text] [Related]
9. [Exacerbation of psoriasis during treatment with H2 antagonists].
Andersen M
Ugeskr Laeger; 1991 Jan; 153(2):132. PubMed ID: 1671185
[No Abstract] [Full Text] [Related]
10. [Hemolytic anemia and thrombocytopenia induced by cimetidine: recurrence with ranitidine administration].
Takimoto R; Mogi Y; Kura T; Niitsu Y
Rinsho Ketsueki; 1997 Feb; 38(2):124-8. PubMed ID: 9059066
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular adverse effects of H2-receptor antagonists].
Hinrichsen H; Kirch W
Dtsch Med Wochenschr; 1994 Apr; 119(14):525-30. PubMed ID: 7908870
[No Abstract] [Full Text] [Related]
12. Outcome of pregnancy after first trimester exposure to H2 receptor antagonists.
Koren G; Zemlickis DM
Am J Perinatol; 1991 Jan; 8(1):37-8. PubMed ID: 1670987
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole, H2 blockers, and polyarthralgia: case-control study.
Meier CR; Jick H
BMJ; 1997 Nov; 315(7118):1283. PubMed ID: 9390057
[No Abstract] [Full Text] [Related]
14. Recurrent parotitis with H2 receptor antagonists.
Caraman P; Netter P; Semin-Cosson AM; Parrot B; Trechot P; Azoulay E
Lancet; 1986 Dec 20-27; 2(8521-22):1455-6. PubMed ID: 2878298
[No Abstract] [Full Text] [Related]
15. A review of epidemiological studies on cancer in relation to the use of anti-ulcer drugs.
La Vecchia C; Tavani A
Eur J Cancer Prev; 2002 Apr; 11(2):117-23. PubMed ID: 11984128
[TBL] [Abstract][Full Text] [Related]
16. H(2) antagonist-induced thrombocytopenia: is this a real phenomenon?
Wade EE; Rebuck JA; Healey MA; Rogers FB
Intensive Care Med; 2002 Apr; 28(4):459-65. PubMed ID: 11967601
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary education ensures successful formulary conversion.
Barfield PS; Amerson AB
Hosp Formul; 1991 Nov; 26 Suppl D():28-9. PubMed ID: 10136563
[TBL] [Abstract][Full Text] [Related]
18. Drug stop. A review of histamine 2-receptor antagonists.
Ambielli MP
J Neurosurg Nurs; 1983 Dec; 15(6):370-3. PubMed ID: 6140303
[No Abstract] [Full Text] [Related]
19. Neurobehavioral syndrome induced by H2-receptor blocker withdrawal: possible role of prolactin.
Rampello L; Raffaele R; Nicoletti G; Le Pira F; Vecchio I; Malaguarnera M; Drago F
Clin Neuropharmacol; 1997 Feb; 20(1):49-54. PubMed ID: 9037573
[TBL] [Abstract][Full Text] [Related]
20. Histamine-2-receptor antagonists and oesophageal cancer.
Fioretti F; Tavani A; La Vecchia C; Franceschi S
Eur J Cancer Prev; 1997 Apr; 6(2):143-6. PubMed ID: 9237063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
